À¯¹æ¾ÏÀÇ À¯¹æÀýÁ¦¼ú ÈÄ ¹ß»ýÇÑ ±¹¼Ò ¹× ±¸¿ª¿¡ ±¹ÇÑµÈ Àç¹ßÀÇ ¼ö¼úÀû Ä¡·á¿¡ µû¸¥ ÀÌÂ÷Àû Àç¹ß ¾ç»ó°ú ¿¹ÈÄ ÀÎÀÚ ºÐ¼®
Pattern of Secondary Failure and Prognostic Factors for Survival Following Surgical Treatment of Isolated Locoregional Recurrence after Mastectomy of Breast Cancer
¼Õº´È£, È«¼ºÈñ, °ÈñÁØ, À±È£¼º, ¾È¼¼Çö,
¼Ò¼Ó »ó¼¼Á¤º¸
¼Õº´È£ ( Son Byung-Ho )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
È«¼ºÈñ ( Hong Seong-Hee )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
°ÈñÁØ ( Kang Hee-Joon )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
À±È£¼º ( Yoon Ho-Sung )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¾È¼¼Çö ( Ahn Sei-Hyun )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
KMID : 0371320030640040282
Abstract
PURPOSE: This study was performed to evaluate the patterns of secondary failure, and the prognostic factors for survival, following surgical treatment of an isolated locoregional recurrence after a mastectomy in breast cancer patients.
METHODS: Forty-nine patients, who had undergone an excision, or a wide excision, either with or without radiation therapy, for an isolated locoregional recurrence following a mastectomy, between 1991 and 2001, were retrospectively analyzed according to the secondary recurrence patterns, the time to the secondary failure, survival rate, and prognostic factors for survival.
RESULTS: During the 33 month median follow-up, 28 patients (57%) developed a secondary recurrence; an isolated locoregional failure in 7 (25%), a systemic dissemination in 20 (71%), and both in 1 (4%). The median times from the first recurrence to the second failure, according to the pattern of the secondary failure, were 16, 14 and 6 months for locoregional, for systemic dissemination, and for both, respectively. The disease-free interval (DFI) from first surgery to the recurrence was a significant independent prognostic factor for the second failure. A Univariate analysis identified the DFI, and hormone therapy administered due to a recurrence, as significant prognostic factors for overall survival, but these were not from a multivariate analysis. The 5-year disease-free and overall survival rates for an isolated locoregional recurrence were 27% and 79%, respectively, compared with 0% for both these rates for a recurrence combined with a systemic recurrence (P=0.002).
CONCLUSION: A secondary failure, following treatment of an isolated locoregional recurrence, developed in more than half the patients, with a locoregional failure in 25%, and a systemic dissemination in the remainder. DFI and hormone therapy for a recurrence were independent prognostic factors of the overall survival. The survival rates after surgical treatment of isolated locoregional recurrences were increased compared with those for a recurrence combined with a systemic recurrence.
Å°¿öµå
À¯¹æ¾Ï;±¹¼Ò ¹× ±¸¿ª Àç¹ß;¼ö¼úÀû Ä¡·á;ÀÌÂ÷Àû Àç¹ß;¿¹ÈÄÀÎÀÚ
Breast cancer;Locoregional recurrence;Surgical treatment;Secondary failure;Prognostic factors
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸